the new york times | Mark Coddington

List

December 23rd, 2011

Buy Tramadol No Prescription

[This review was originally posted at the Nieman Journalism Lab Buy Tramadol No Prescription, on Nov. 4, 2011.]

Should we rethink online paywalls?: It may not be grabbing as many headlines as it was a year ago, but the paid-content train keeps rollin' along, with two more newspapers jumping on board this week: Britain's The Independent is launching a metered paywall for readers outside the U.K. (powered by the Press+ system formerly of Journalism Online), and the Minneapolis Star Tribune is launching a metered model similar to that of the New York Times — 20 free page views a month, Cheap Tramadol no rx, after which the paywall kicks in. Print subscribers will have unlimited access, and the Strib estimates that it'll eventually get $3 million to $4 million in annual revenue from the plan.

On another paywall front, the Lab's Justin Ellis reported that Google, which has been working with publishers on paid content online for a while, has been quietly experimenting with a survey-as-paywall, in which visitors are asked to answer a survey question in order to gain access to the site, japan, craiglist, ebay, overseas, paypal.

This week's quarterly circulation numbers included some positive news about the New York Times' paywall, as Ken Doctor noted at the Lab last week: The New York Times' Sunday circulation actually went up, for the first time in five years, Buy Tramadol No Prescription. Poynter's Rick Edmonds pointed out that this quarter's numbers are the result of a formula in flux, but the good signs have people like NPR's David Folkenflik rethinking the value of online news paywalls.

Not everyone's high on paywalls, of course: After initially being surprised by the high numbers of subscribers to Newsday's online edition, Forbes' Jeff Bercovici found that the number paying for it on its own is still under 1,000. Is Tramadol safe, And GigaOM's Mathew Ingram said that despite its initial success, the Times' paywall is still a stopgap strategy — "an attempt to create the kind of artificial information scarcity that newspapers used to enjoy. And if that is all that newspapers are trying to do, the future looks pretty bleak indeed."

—

Yahoo's new personalized news app: Yahoo jumped into the tablet world this week, announcing the launch of several products for the iPad, including the social TV app IntoNow and Livestand, a "personalized living magazine" (yup, another one), discount Tramadol. Buy Tramadol No Prescription, The obvious point of comparison is Flipboard, and opinions were varied as to how well Livestand compares to Flipboard. Mashable's Ben Parr was pretty impressed, though he noted that Livestand and Flipboard are gathering their content in different ways — Flipboard through your social feeds, and Livestand through its content partners.

Others weren't quite so wowed. Kara Swisher of All Things Digital said Livestand shouldn't be anything new for Flipboard users, and Wired's Tim Carmody saw the difference between Flipboard and Livestand that Parr mentioned as a fundamental error by Yahoo. Tramadol overnight, Flipboard is built for readers, to allow them to distill the good stuff from their social and RSS feeds, he said. But "Yahoo’s Livestand only solves problems for publishers and advertisers: how to display content and advertising to readers without having to have everyone write their own code from scratch." The Lab's Ken Doctor gave several useful areas in which to evaluate Livestand and the coming tablet aggregator wars, Buy Tramadol No Prescription.

Advertising is a big part of what's new with Livestand: With it, they also unveiled Living Ads, which is the latest attempt to create a magazine-like ad on the tablet, using HTML5. As Adweek noted, generic Tramadol, the ads take up a third of the screen and are interactive, with animation and video available. These ads are pretty expensive, but Yahoo's Blake Irving told Business Insider they get advertisers away from the CPM model, which he believes hasn't served advertisers well.

—

Is Assange a step closer to the U.S.?: A week after WikiLeaks announced that it would temporarily shut down to raise money, Tramadol from canada, the whistleblowing website got some more bad news when a British high court ruled that WikiLeaks' founder, Julian Assange, can be extradited to Sweden on charges of sexual assault, rejecting an appeal of a ruling made earlier this year. Buy Tramadol No Prescription, Assange can still appeal to Britain's Supreme Court, but it's headed to Sweden to face trial.

Assange has opposed the extradition to Sweden because he contends that the rulers of that country are aligned against him, but the specter of another extradition is also looming: As Paul Sawers of The Next Web noted, Assange and his supporters are concerned that a move to Sweden would make it much easier for him to be sent to the United States, where the Obama administration and members of Congress have discussed prosecuting him for releasing sensitive information through WikiLeaks, where can i order Tramadol without prescription. Forbes' Andy Greenberg argued, however, that Assange would be more likely to be sent to the U.S. from Britain than from Sweden.

The Associated Press looked at whether WikiLeaks could survive Assange's extradition — its answer: probably not — and Swedish columnist Karin Olsson wrote in the Guardian that Assange has lost all of his intriguing man-of-mystery status in her country. But Australian journalist Matt da Silva urged people not to let up in their support of Assange, praising him as a crusader against government's efforts to manage and control the media, Buy Tramadol No Prescription.

—

Reconciling journalism and political views: What started a couple of weeks ago as yet another public radio conundrum regarding its employees and political opinions morphed into an interesting discussion about journalism and transparency. My Tramadol experience, Two public radio employees, Lisa Simeone of Soundprint and Caitlin Curran of WYNC's The Takeaway, were fired after taking part in Occupy Wall Street protests. Curran told her story at Gawker, and Brooke Gladstone, host of the NPR show On the Media, discussed NPR's policy in a live chat.

The Atlantic's Conor Friedersdorf argued that WNYC was wrong to fire Curran, buy Tramadol without prescription, pointing out that several NPR reporters have made essentially the same point she did in her protest sign, and have been praised for it. He and the Guardian's Dan Gillmor also made the case Buy Tramadol No Prescription, for doing away with the philosophy of viewlessness in the American press. As Gillmor put it, telling journalists they can't even hint at what they believe "puts a barrier between them and their audiences – a serious problem given that news and journalism are evolving from a lecture into a conversation." Though he wasn't discussing the public radio firings, Gawker's Hamilton Nolan did provide a counterargument, defending journalistic facelessness and an institutional writing style. Tramadol trusted pharmacy reviews, And as if on cue, former New York Sun editor Ira Stoll launched News Transparency, a site that lets people know about journalists' backgrounds as a kind of imposed transparency from the outside, as Poynter's Jeff Sonderman put it.

—

The Verge takes off: A new tech blog to watch: The sports blog network SB Nation launched a tech blog called The Verge this week, under the leadership of several former Engadget staffers. As part of the launch, SB Nation and The Verge will both fall under a new parent media called Vox Media, where can i buy cheapest Tramadol online. The site got some initial rave reviews over its updating story streams, something that SB Nation has been using for a while, Buy Tramadol No Prescription.

Business Insider has an interview with the folks behind the site, and the Lab's Justin Ellis talked about where SB Nation/Vox will go from here. The Lab's Joshua Benton also pulled three lessons for news orgs out of the site's development, emphasizing bold, tablet-style design, structured data, Tramadol class, and community.

—

Reading roundup: Tons of stuff going on this week. Here's the TL;DR version of the rest:

— Google began giving journalists photos next to their stories in Google News — but only if they have a Google+ account. Alexander Howard was OK with it Buy Tramadol No Prescription, , but Columbia's Emily Bell wasn't, calling it coercion and saying it only helped Google, not journalism.

— The St. Petersburg Times, a newspaper owned by the nonprofit Poynter Institute, announced it will change its name to the Tampa Bay Times on Jan. 1, order Tramadol online c.o.d, broadening its geographic focus. Poynter rounded up some of the reaction on social media and compared the decision to other recent newspaper name changes.

— Your weekly News Corp, Buy Tramadol No Prescription. phone hacking update: New documents released by a committee of Britain's Parliament revealed that a company attorney warned of a culture of hacking back in 2008. Here's the summary from News Corp.'s own Wall Street Journal and a blow-by-blow from the Guardian.

— As GigaOM's Colleen Taylor reported, Twitter has quietly unveiled new Top News and Top People search functions. Tramadol photos, Poynter's Jeff Sonderman looked at the effect it will have on publishers.

— Media analyst Frederic Filloux examined the sad state of web news design, and Amy Gahran of the Knight Digital Media Center said all the ugliness could help push users to the mobile web.

— The Guardian launched n0tice, their open community news platform. The Lab's Megan Garber took a look at the new site, and The Next Web's Martin Bryant examined it as a possible replacement for local newspapers.

— Finally, here's hoping this inspiring Lab post by Jacob Harris will forever put an end to the insipid question, "Will X save journalism?".

September 16th, 2011

Cipro Dosage

[This review was originally posted at the Nieman Journalism Lab Cipro Dosage, on Sept. 16, 2011.]

Paid and free, side by side: The Boston Globe became the latest news organization to institute an online paywall this week, but it did so in an unprecedented way that should be interesting to watch: The newspaper created a separate paid site, BostonGlobe.com, Order Cipro from United States pharmacy, to run alongside its existing free site, Boston.com. PaidContent has the pertinent details: A single price ($3.99 a week), and Boston.com gets most of the breaking news and sports, while BostonGlobe.com gets most of the newspaper content. The Lab's Justin Ellis, meanwhile, buy no prescription Cipro online, has a look at the lab that designed it all.

As the Globe told Poynter's Jeff Sonderman, the two sites were designed with two different types of readers in mind: One who has a deep appreciation for in-depth journalism and likes to read stories start-to-finish, and another who reads news casually and briefly and may be more concerned about entertainment or basic information than journalism per se.

The first thing that caught many people's attention was new site's design — simple, clean, and understated, Cipro Dosage. Tech blogger John Gruber gave it a thumbs-up, Buy Cipro without prescription, and news design guru Mario Garcia called it "probably the most significant new website design in a long time." The Lab's Joshua Benton identified the biggest reasons it looks so clean: Far fewer links and ads.

Benton (in the most comprehensive post on the new site) also emphasized a less noticeable but equally important aspect of BostonGlobe.com's design: It adjusts to fit just about any browser size, which eliminates the need for mobile apps, making life easier for programmers and, as j-prof Dan Kennedy noted at the Lab, a way around the cut of app fees required by Apple and others. If the Globe's people "have figured out a way not to share their hard-earned revenues with gatekeepers such as Apple and Amazon, then they will have truly performed a service for the news business — and for journalism, Cipro trusted pharmacy reviews," Kennedy said.

Of course, the Globe could launch the most brilliantly conceived news site on the web, but it won't be a success unless enough people pay for it. Poynter's Sonderman (like Kennedy) was skeptical of their ability to do that, Ordering Cipro online, though as the Atlantic's Rebecca Rosen pointed out, the Globe's plan may be aimed as much at retaining print subscribers as making money off the web. The Washington Post's Erik Wemple wondered Cipro Dosage, if readers will find enough at BostonGlobe.com that's not at Boston.com to make the site worth their money.

—

The TechCrunch conflict and changing ethical standards: Last week's flap between AOL and TechCrunch over the tech site's ethical conflicts came to an official resolution on Monday, when TechCrunch founder Michael Arrington parted ways with AOL, the site's owner. But its full effects are going to be rippling for quite a while: Gawker's Ryan Tate called the fiasco a black eye for everyone involved, but especially AOL, Cipro samples, which had approved Arrington's investments in some of the companies he covers just a few months ago. Fellow media mogul Barry Diller also ripped AOL's handling of the situation.

At the Guardian, Dan Gillmor said that while he doesn't trust TechCrunch much personally, it's the audience's job to sort out their trust with the help of transparency, Cipro recreational, rather than traditional journalism's strictures. Others placed more of the blame on TechCrunch: Former Newsweek tech editor Dan Lyons said TechCrunch's people should have expected this type of scenario when they sold to a big corporation, and media analyst Frederic Filloux said TechCrunch is a perfect example of the blogosphere's vulnerability to unchecked conflicts of interest.

There was more fuel for those kinds of ethical concerns this week, as the winning company at TechCrunch's annual Disrupt competition was one that Arrington invests in, Cipro Dosage. But Arrington had an ethical accusation of his own to make at the conference, pointing out that the New York Times invests in a tech venture capital fund which has put $3.5 million into GigaOM, a TechCrunch competitor. Poynter's Steve Myers detailed the Times' run-ins between the companies it invests in and the ones it covers (and its spotty disclosure about those connections), concluding that even if the conflict is less direct than in blogging, comprar en línea Cipro, comprar Cipro baratos, it's still worth examining more closely.

As it plunged further into its battle with TechCrunch late last week, AOL was also reported to be talking with Yahoo, which recently fired its CEO, about a merger between the two Internet giants. Cheap Cipro no rx, All Things Digital's Kara Swisher said there's no way the deal would actually happen, and Wired's Tim Carmody called it a "spectacularly crazy idea" and GigaOM's Mathew Ingram agreed, while Business Insider reminded us that they said a year ago that AOL and Yahoo should merge. Cipro Dosage, Meanwhile, the New York Times' David Carr homed in on the core problem that both companies are facing: The fact that people want information online from niche sites, not giant general-news portals. "As news surges on the Web, giant ocean liners like AOL and Yahoo are being outmaneuvered by the speedboats zipping around them, relatively small sites that have passionate audiences and sharply focused information," he wrote.

—

Facebook opens to subscribers: It hasn't gotten nearly as much attention as some of its other moves, but Facebook took another step in Twitter's direction this week by introducing the Subscribe Button, which allows users to see other people's (and groups') status updates without friending or becoming a fan of them.

As GeekWire's Monica Guzman and many others noted, buy cheap Cipro no rx, Facebook's "subscribe" looks a heck of a lot like Twitter's "follow." When asked about similar Google+ features at the TechCrunch Disrupt conference, a Facebook exec said it wasn't a response to Google+.

Guzman said Facebook is putting down deeper roots by going beyond the limits of reciprocal friendship, and GigaOM's Mathew Ingrampinpointed the reason why this could end up being a massive change for Facebook: It's beginning to move Facebook from a symmetrical network to an asymmetrical one, which could fundamentally transform its dynamics. Still, Cipro brand name, Ingram said Twitter is much better oriented toward being an information network than Facebook is, even with a "Subscribe" button.

The change could have particularly interesting implications for journalists, as Poynter's Jeff Sonderman explained in his brief outline of the feature. As he noted, it may eliminate the need for separate Facebook profiles and pages for journalists, and while Lost Remote's Cory Bergman said that should be a welcome change for journalists who were trying to manage both, he noted that shows and organizations may want to stick with pages, Cipro Dosage.

—

News Corp.'s scandal widens: An update on the ongoing scandal enveloping News Corp.: A group of U.S. banks and investment funds that own shares in News Corp. expanded a lawsuit to include allegations of stealing, hacking, purchase Cipro for sale, and anti-competitive behavior by two of the company's U.S. subsidiaries — an advertiser and a satellite TV hardware manufacturer. As the Washington Post's Erik Wemple noted, these are old cases, but they're getting fresh attention, Cipro dosage, and that's how scandals gain momentum. Cipro Dosage, James Murdoch, the son of News Corp.'s Rupert Murdoch, was also recalled to testify again before members of Britain's Parliament later this fall, facing new questions about the breadth of News Corp.'s phone hacking scandal. The Wall Street Journal examined the scandal's impact on the elder Murdoch's succession plan for the conglomerate, especially as it involves James. The company's executives also announced this week that they've found tens of thousands of documents that could shed more light on the phone hacking cases.

—

Reading roundup: Here's what else went on this week:

— The biggest news story this week, of course, is actually 10 years old: Here's a look at how newspapers marked the anniversary of 9/11, real brand Cipro online, how news orgs used digital technology to tell the story, and a reflection on how 9/11 changed the media landscape.

— Twitter introduced a new web analytics tool to measure Twitter's impact on websites. Here's an analysis from Mathew Ingram of GigaOM, Cipro Dosage.

— At an academic conference last weekend, Illinois j-prof Robert McChesney repeated his call for public funding for journalism. Purchase Cipro online no prescription, Here are a couple of good summaries of his talk from fellow j-profs Axel Bruns and Alfred Hermida.

— Finally, here's a relatively short but insightful two-part interview between two digital media luminaries, Henry Jenkins and Dan Gillmor, about media literacy, citizen journalism and Gillmor's latest book. Should make for a quick, thought-provoking weekend read.

September 16th, 2011

Cephalexin Price

[This review was originally posted at the Nieman Journalism Lab Cephalexin Price, on Aug. 19, 2011.]

Is social media killing big ideas?: In the New York Times this week, USC fellow Neal Gabler put forward a different form of the familiar "information overload" complaint, this time tying the proliferation of social media to the paucity of big ideas. We don't spend time thinking about and valuing big ideas, Cephalexin from canada, he argued, because we're too busy trying to process — and add to — the flood of information coming at us through social media. You can't think and tweet at the same time, Gabler said, because tweeting "is a form of distraction or anti-thinking."

Naturally, this didn't go over particularly well among the online media punditry. Several people countered that one of Twitter's functions is to direct users to big ideas, no prescription Cephalexin online, to point outside of its 140-character limits through hyperlinks. Media prof Chuck Tryon, author Stephen Baker, and Techdirt's Mike Masnick all made that argument, with Masnick summing it up well: "While social media may not have enlarged Gabler's intellectual universe, it has massively enlarged mine, Cephalexin Price. Thanks to Twitter specifically, I've been able to meet tons of fascinatingly smart people I never would have met otherwise." The trick, as Baker said, is to "listen to the right people, Cephalexin interactions, and then follow their links."

Two other writers made particularly smart points: Kevin Drum of Mother Jones noted that where before we knew exactly where to find big ideas and how to discuss them, we're now in the middle of a massive media transition. That doesn't mean the big idea is dead, he said, it means it's headed somewhere new, and we don't know exactly where yet. And the Lab's Megan Garber pointed out that Gabler's vision of big ideas is closely tied to big media, buy Cephalexin online cod, but argued that those big ideas don't need big media to thrive. Instead, she said, "Increasingly, though, Cephalexin australia, uk, us, usa, the ideas that spark progress are collective, diffusive endeavors rather than the result (to the extent they ever were) of individual inspiration."

—

A paywall plan that understands online readers?: Reuters blogger Felix Salmon is already on record as a supporter of the New York Times' five-month-old paywall, and this week he detailed exactly why he thinks it's so effective. Cephalexin Price, Salmon likened the Times' metered model, with all of its leeway and potential workarounds, to a polite "Please keep off the grass" sign. He argued that contra the prevailing philosophy that readers won't pay for something they can get for free, the Times is betting that "the pleasure of reading its content will be enough to persuade a large number of people to pay. It’s a far more attractive model, and one which is much more likely to attract new young subscribers over the long term."

In a follow-up post, buy cheap Cephalexin, Salmon explained why the Times' model is fundamentally different from the Financial Times' pay meter — it's not trying nearly as hard to keep non-subscribers away from its content. Venture capitalist Fred Wilson and Poynter's Jeff Sonderman agreed with Salmon's premise: Wilson praised the efficacy of getting paid after the fact rather than before, and Sonderman said the Times has discovered that convenience, duty, and appreciation are more compelling motivations than coercion. Cephalexin over the counter, There was one notable dissenter: GigaOM's Mathew Ingram, who took issue with the idea that the Times' plan has been successful, arguing instead that it's not growing the paper's online audience, but setting up digital sandbags to protect a declining print product. The plan "has virtually nothing to do with actually taking advantage of the digital world in any concrete way," Ingram wrote, Cephalexin Price. "It’s just charging people nickels and dimes for their paper, the way the NYT and other newspapers have for a century and a half or so."

—

News Corp.'s problems continue to grow: The damning information against News Corp. in the phone-hacking scandal at its former News of the World newspaper keeps on coming, Cephalexin no rx. This week, it was a four-year-old letter written by Clive Goodman, a reporter at the center of the scandal. In it, Goodman said that the hacking was discussed regularly at the paper and suggested that knowledge of it ran much deeper than News Corp. Cephalexin Price, has been insisting. Ordering Cephalexin online, Notably, News Corp. had submitted the letter to Parliament but redacted the incriminating parts.

With the new revelation, Slate's Jack Shafer wrote that "the scandal has grown too large for one or two willing Murdoch lieutenants or employees to stanch it by taking the fall." That impression has led many watchers to wonder, as the Guardian's Brian Cathcart did, if James Murdoch, Cephalexin recreational, Rupert's son, may be forced to resign. James responded late last week to Parliament's questions about his truthfulness in his testimony to them last month, and News Corp. is reportedly making plans in case he decides to step aside, Cephalexin Price.

The bad news continues to pile up elsewhere in News Corp., Cephalexin photos, too. The private investigator at the center of the scandal sued News International (the company's British newspaper division) for not paying his legal bills, and officially acknowledged in its annual report that the scandal could impair its business, and that it doesn't know how much money it'll end up costing. Two more commentators — the New Yorker's Ken Auletta and Reuters' David Callahan — echoed a popular sentiment lately, saying the responsibility for this whole ordeal lies directly with Rupert Murdoch.

—

Google grabs a mobile-phone producer: For the tech geeks among us, buy Cephalexin online no prescription, Google made some big news this week, buying Motorola Mobility, Motorola's mobile devices division, for $12.5 billion. According to the New York Times Cephalexin Price, , the deal had a lot to do with stockpiling patents in order to defend its Android mobile operating system from patent lawsuits. It also may allow Google to drive down development costs for the all-important smartphone and tablet markets. Order Cephalexin online c.o.d, Cory Bergman of Lost Remote noted that this move isn't just about mobile, though — it also represents Google's biggest move into TV yet. With Motorola's significant share of the cable-TV hardware business, Bergman said, Google now has the opportunity to seamlessly integrate its technology with TVs across the world.

Here at the Lab, Joshua Benton used the acquisition as an example of the tension between a Windows-style modular approach to business, buy Cephalexin without a prescription, with products that can be swapped in and out, and an Apple-esque interdependent one, with a set of interlinking, proprietary products. He also applied the idea to news, saying our journalistic ecosystem needs both the more open modular approach and the more packaged interdependent approach, Cephalexin Price.

A couple of other posts looked at the story of the deal itself: Reuters' Felix Salmon examined the decline (and declining value) of the financial scoops beat, Cephalexin schedule, and Gawker's Ryan Tate saw Google's manufactured press-release quotes by its business partners as a sign that Google is moving away from the "Don't Be Evil" mantra toward being a tight-fisted corporate giant.

—

Reading roundup: This week was a pretty packed one. Here's the best of the rest:

— This week in AOL: The New York Times' Verne Kopytoff analyzed why the new-look AOL has experienced so many hiccups, and j-prof Dan Kennedy seized on the tidbit in that article that AOL would reportedly be profitable without Patch.

— Web philosopher David Weinberger wrote a fantastic piece about the journalistic curiosity and community exchange that's present at Reddit, and GigaOM's Mathew Ingram echoed his thoughts.

— The Knight Digital Media Center's Joy Mayer has apparently become journalism's "Minister of Engagement," and she's earned the title, publishing a thorough guide to community engagement for newsrooms.

— The Online Journalism Review's Robert Niles wondered what journalism is worth, and came up with some depressing answers.

— Finally, since classes are starting up all over the place in the next week or two, here's 10 great tips for journalism students from Sarah Marshall of Journalism.co.uk, via Twitter.

August 13th, 2011

Buy Retin A No Prescription

[This review was originally posted at the Nieman Journalism Lab Buy Retin A No Prescription, on Aug. 12, 2011.]

Murdoch passes Wall Street's test: The fallout from News Corp.'s phone hacking scandal continued to spread this week, with the reported arrest of another former News of the World editor and the report that the ostensibly fired News Corp. British chief, Rebekah Brooks, Retin A alternatives, is still on the company payroll.

Three weeks after testifying before Parliament, Rupert Murdoch faced Wall Street analysts this week in a conference call, telling them that he's not going anywhere and that the scandal hasn't done any material damage to the company outside of News of the World. Purchase Retin A, All Things Digital's Peter Kafka said Wall Street really doesn't care about the hacking, and Murdoch didn't say much about the few questions he did get on it.

Murdoch also had to meet with News Corp.'s board, but as the New York Times' Jeremy Peters reported, the board's officially independent members include numerous people who have deep personal ties to Murdoch, Buy Retin A No Prescription. Perhaps more troubling was a different connection among one of the board members: According to Time's Massimo Calabresi, one of them is "best friends" with the district attorney leading the U.S. investigation into the company.

The Times' David Carr uncovered more hints at News Corp.'s enormous political influence here in the States, Retin A pics, detailing cases of swift approval of a merger by a Justice Department unit led by a future News Corp. executive, as well as a suspiciously dropped federal criminal case. "The company’s size and might give it a soft, less obvious power that it has been able to project to remarkable effect, Buy Retin A without prescription, " Carr concluded. Buy Retin A No Prescription, At Adweek, Murdoch biographer Michael Wolff went further, reporting that the Justice Department is considering investigating News Corp. on racketeering charges, though Forbes' Jeff Bercovici doubted that would happen. For a bit more info on the situation, here's a good Q&A with Nick Davies, the Guardian reporter who's been all over the story, order Retin A no prescription.

—

AOL's slap from investors: This week hasn't been a good one for AOL: After it reported a quarterly loss on Tuesday, its stock dropped by about a quarter by the end of the day. All Things Digital's Peter Kafka gave a quick explainer of why investors are so down on AOL: What little money they're making isn't coming from the all-important display advertising business. Mathew Ingram of GigaOM added more depth to that analysis, arguing that investors are doubting AOL's assurances that its two big gambles — Patch and the acquisition of the Huffington Post — will pay off, Buy Retin A No Prescription.

According to AOL CEO Tim Armstrong (paraphrased by Business Insider), Retin A price, coupon, the reason for those problems is that AOL's advertising side hasn't scaled well enough. Peter Kafka explained that AOL's advertising (especially display) is indeed up, though much of that can be attributed to the HuffPo and TechCrunch acquisitions. Forbes' Jeff Bercovici said AOL's public image problem has even damaged the previously successful HuffPo, quoting an analyst who called AOL a "dead brand." Wired's Tim Carmody decided to unite our two big stories this week and suggested that AOL would be a perfect fit for a purchase by News Corp.

Meanwhile's AOL's local-news initiative, Retin A samples, Patch, launched a Groupon-esque daily deal service, and Iowa grad student Robert Gutsche Jr.questioned Patch's standards for separating journalism and advertising — and got the runaround from Patch when he asked them about it. AOL's new daily tablet magazine, Editions, Buying Retin A online over the counter, also drew some criticism, with Fast Company's Austin Carr perturbed that it's not AOL-y enough.

—

A news org gets into tablets Buy Retin A No Prescription, : We've already seen numerous challengers to the iPad's early stranglehold on the tablet marketplace, but the Tribune Co. might be the first news company to try one out. CNN's Mark Milian reported that the newspaper chain is working on an Android-based tablet, which it's planning on offering it for free or very cheap to people who sign up for extended newspaper subscriptions. It's already missed a mid-August deadline for testing the tablet out, purchase Retin A online.

Media pundits didn't think much of the Tribune's idea. Wired's Tim Carmody urged the Tribune (and media companies in general) to quit developing tablets, arguing that it's way too hard to do if you're a major development company, let alone a news organization. "If major publishers are seriously prepared to blow up their primary revenue stream — print advertising — and slap together a giveaway tablet in order to save money on ink, God help them," he wrote, Buy Retin A No Prescription.

Others echoed Carmody's arguments: PaidContent's Tom Crazit called the project "a colossal waste of money for a company trying to emerge from bankruptcy." Chris Velazco of TechCrunch said the cheap-tablet model (also being talked about by Philadelphia Newspapers) isn't viable. Gizmodo's Brent Rose was less restrained: "WHY??" Morris Communications' Steve Yelvington was a little kinder to the Tribune, saying the numbers might add up, Kjøpe Retin A på nett, köpa Retin A online, but the devil's in the details.

—

The Times gets experimental: The New York Times has frequently made strong pushes into news innovation over the past several years, and this week it started another one, launching a new public test kitchen for projects in development. The Lab's Megan Garber explained what the site, beta620, Retin A for sale, is all about, but GigaOM's Mathew Ingram, while applauding the effort, expressed some doubt about whether the Times is really capable of developing a startup's mindset. Buy Retin A No Prescription, Tim Carmody of Wired, on the other hand, said the startup analogy isn't the right one for the Times. Retin A online cod, With these projects, he said, "The New York Times has become an openly experimental public institution. It’s less a cathedral consecrated to its own past than a free museum where patrons are invited to touch and transform everything they see." Poynter's Jeff Sonderman had some suggestions for next steps for the Times to take with beta620: experimenting with design, getting away from the long narrative article, and rethinking comments, Retin A trusted pharmacy reviews.

—

The real-name debate: One long-simmering debate I want to briefly catch you up on: Google+ has decided to take the Facebook route of disallowing pseudonyms, adjusting but reaffirming its policy in the face of online criticism late last month and again on Thursday. The outcry continued, voiced most prominently late last week by social media researcher danah boyd, Order Retin A from mexican pharmacy, who asserted that "'real names' policies aren’t empowering; they’re an authoritarian assertion of power over vulnerable people."

Liz Gannes of All Things Digital said she understands Google's motivations for enforcing real names and unifying everything under its umbrella within the same identity, but the idea of doing the latter is awkward at best and frightening at worst. The Atlantic's Alexis Madrigal, meanwhile, announced he's changed his mind against real-name policies, arguing that requiring real names online is a radical departure from the relationship between speech and identity in the offline world, Buy Retin A No Prescription.

—

Reading roundup: A few other things to keep an eye on this week:

— Amazon released a version of its Kindle app for browsers, called the Kindle Cloud Reader. GigaOM's Mathew Ingram said the browser-based e-book app (which bypasses Apple's restrictions) could be a roadmap for the future of the web, but Wired's Tim Carmody said it still doesn't get the web, Retin A without prescription.

— Google announced it's making its hand-chosen Editors' Picks a standing feature on Google News. The Lab's Megan Garber explained what Google's doing with it. Buy Retin A No Prescription, Meanwhile, James Gleick at The New York Review of Books offered a thoughtful piece on Google's domination of our online lives.

— Adweek explained an underrated obstacle to innovation and progress in news organizations' online efforts: the intractable CMS.

— Steve Buttry, now with the Journal Register Co., gave his lessons from TBD's demise on the Washington local news site's first birthday. It's short but solid. Enjoy.

August 13th, 2011

Purchase Retin A

[This review was originally posted at the Nieman Journalism Lab Purchase Retin A, on July 29, 2011.]

Debating the Times' paywall and design: In its quarterly earnings call late last week, the New York Times gave the clearest picture yet of how its new online pay plan is working. As usual, it turned out to be something of a Rorschach test: BNET's Erik Sherman called the numbers evidence that the paywall isn't protecting the Times' print subscriptions, as it was intended to. On the other hand, the Columbia Journalism Review's Ryan Chittum argued that the Times' big digital subscription figure (224, Retin A images,000) "proves that, contra the naysayers, readers will pay good money for quality news." The Times' paywall adds an important digital revenue stream, he said, Online Retin A without a prescription, while also letting in enough casual readers to keep the value of digital advertising up.

The most thorough defense of the Times, though, came from New York magazine's Seth Mnookin: "The Times has taken a do-or-die stand for hard-core, boots-on-the-ground journalism, for earnest civic purpose, low dose Retin A, for the primacy of content creators over aggregators, and has brought itself back from the precipice."BNET's Jim Edwards said it's premature for Mnookin to say the Times is back, but Reuters' Felix Salmon, a former Times paywall skeptic, Where can i order Retin A without prescription, agreed with Mnookin that the paywall is working, saying he's glad the Times has shown a porous paywall can work.

The other Times-related item is firmly in the hypothetical realm, but it generated at least as much conversation as the real-world pay plan. Last week, web designer Andy Rutledge critiqued the Times' online design and proposed his own version, emphasizing headlines, time stamps, authors, and separating news from opinion, Purchase Retin A.

The response wasn't particularly positive. The redesign was generally trashed on Twitter, Retin A natural, with a typical sentiment expressed by 10,000 Words' Lauren Rabaino: "It’s hard to take seriously a design that completely ignores the constraints of a typical newspaper." One of the most comprehensive responses came from Guardian developer Martin Belam, who pointed out things like faces, article summaries, Retin A overnight, and points of social connection that Rutledge was missing.

The Lab's Joshua Benton argued that Rutledge's redesign doesn't acknowledge that "the problems of large-scale information architecture for news sites are really hard problems." Meanwhile, Belgian developer Stijn Debrouwere went the other direction, asking for more unrealistic mockups like this one to help us brainstorm what news sites could look like. GigaOM's Mathew Ingram said the problem with the Times' site is that it's designed as if readers are interested in everything the paper produces, which is almost never the case, is Retin A addictive. And Paul Scrivens said both Rutledge and the Times should look outside the news industry Purchase Retin A, for design cues.

—

Google+ growing pains: Google+ continues to grow at a ridiculous pace — far faster than either Facebook or Twitter, as Idealab's Bill Gross pointed out — and as Simon Dumenco of Ad Age argued, the platform represents a social media do-over for a lot of users. It's still generating dissent, Australia, uk, us, usa, though, with much of it stemming from Google+'s policy toward business pages. As Google's Christian Oestlien wrote late last week, the company is working on a business profile template that will be up in the next few months, but they're deleting business pages (including news organization pages) in the meantime.

A few companies will get trial pages before they're available to everyone, Retin A steet value, and others have found workarounds — the tech blog Mashable managed to keep all its followers by simply changing its page name to the name of its CEO, Pete Cashmore. That got other members of the tech press worked up, including Search Engine Land's Danny Sullivan, who urged Google to restore the deleted pages and let businesses create pages normally, Purchase Retin A. TechCrunch's MG Siegler said Google is essentially creating its own version of Twitter's Suggested User List, and Mathew Ingram of GigaOM made the case for why this is a big deal. Retin A from mexico, Elsewhere in the world of Google+, Mathew Ingram wrote about the issues it's dealing with regarding anonymity, and the Atlantic's Alexis Madrigal is experimenting with a daily news roundup on his personal page there. The Next Web's Martin Bryant examined Google+'s usefulness as a news tool, concluding that while it has potential, it needs a bigger, Retin A pictures, broader user base to start to really challenge Twitter and Facebook.

—

The end of media moguls?: The News Corp. Purchase Retin A, phone hacking scandal shifted down a gear this week, but there were still a few developments to report. The News of the World hacking victims also reportedly included the mother of an 8-year-old murder victim, and two former employees testified that they had told James Murdoch that the hacking was widespread, Retin A wiki, contradicting what Murdoch had told Parliament last week. Other News Corp. veterans challenged the picture Rupert Murdoch painted of himself as a largely hands-off newspaper boss.

The New York Times' David Carr wrote that James Murdoch is done, and that Rupert has finally been revealed as vulnerable. CUNY j-prof Jeff Jarvis was more emphatic, calling Murdoch the last media mogul: "The mogul is extinct, Purchase Retin A. The kind of big media institution he built will follow him, Retin A price. Lovely chaos will follow. It’s called democracy." The Washington Post's Erik Wemple took a quick look at what a post-Murdoch world might look like.

A couple of other News Corp.-related avenues to chase down: Dean Starkman of the Columbia Journalism Review argued that a scandal like News of the World's won't happen in the U.S., and News Corp.'s newest property, Retin A blogs, the tablet publication The Daily, appears to be floundering, according to a New York Observer feature, though a new version was released last week.

—

Reading roundup Purchase Retin A, : There wasn't a whole lot to take in this week, but here's a quick sampling:

— The FCC is releasing a series of studies on media ownership, one of the newest of which suggested that media cross-ownership (ownership of multiple media outlets within a single market) doesn't hurt local news, and may actually help it.

— Wisconsin j-prof Stephen Ward made a thoughtful case for redefining objectivity in the digital age.

— Particularly for the Twitter skeptics and writing teachers out there, Retin A brand name, Poynter's Mallary Jean Tenore put together a great post outlining the ways Twitter has made her a better writer.

— Finally, I've been trying to cover this piecemeal discussion here, but the AP's Jonathan Stray did a much better job of summarizing the recent conversation about the changing structure of news stories with a fantastic reading list. Now that you're done with this link-fest, be sure to give that one a look-through, too.

Mark Coddington

Associate Professor, Washington and Lee University

Buy Tramadol No Prescription

Cipro Dosage

Cephalexin Price

Buy Retin A No Prescription

Purchase Retin A